药品名称VIAGRA
申请号020895产品号002
活性成分SILDENAFIL CITRATE市场状态处方药
剂型或给药途径TABLET;ORAL规格EQ 50MG BASE
治疗等效代码参比药物
批准日期1998/03/27申请机构PFIZER IRELAND PHARMACEUTICALS
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
64690122019/10/22U-155PDF格式
6469012*PED2020/04/22PDF格式
历史专利信息
52505342012/03/27PDF格式
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020895045APLetter2015/09/17下载
020895045APLabel2015/09/23下载
020895044APLetter2015/03/27下载
020895044APLabel2015/03/27下载
020895042APLabel2014/03/11下载
020895042APLetter2014/03/11下载
020895039APLabel2014/03/11下载
020895039APLetter2014/03/11下载
020895036APLabel2011/01/31下载
020895036APLetter2011/02/04下载
020895033APLetter2010/01/15下载
020895033APLabel2010/01/20下载
020895029APLetter2008/08/13下载
020895028APLetter2008/08/13下载
020895027APLabel2007/10/18下载
020895027APLetter2007/10/22下载
020895026APLabel2008/02/26下载
020895026APLetter2008/02/27下载
020895023APLabel2006/10/11下载
020895023APLetter2006/10/13下载
020895021APLabel2005/07/08下载
020895021APLetter2005/07/15下载
020895020APLabel2006/06/28下载
020895020APLetter2006/07/03下载
020895018APLetter2002/09/19下载
020895018APLabel2002/09/19下载
020895015APLetter2002/09/19下载
020895015APLabel2002/09/19下载
020895011APLetter2002/09/19下载
020895011APLabel2002/09/19下载
020895003APReview2008/02/19下载
020895002APReview2008/02/19下载
020895001APReview2008/02/19下载
020895000APReview2009/04/13下载
020895000APLetter1998/03/27下载
020895000APLabel1998/03/27下载
020895000APOther Important Information from FDA2007/10/30下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020895045AP2015/09/16Labeling Revision
020895044AP2015/03/26Labeling Revision
020895043AP2015/01/26Manufacturing Change or Addition
020895042AP2014/03/11Efficacy Supplement with Clinical Data to Support
020895041AP2014/03/25Manufacturing Change or Addition
020895040AP2015/02/03Manufacturing Change or Addition
020895039AP2014/03/11Labeling Revision
020895036AP2011/01/31Labeling Revision
020895033AP2010/01/11Labeling Revision
020895029AP2008/08/06Labeling Revision
020895028AP2008/08/06Labeling Revision
020895027AP2007/10/18Labeling Revision
020895026AP2008/02/25Labeling Revision
020895023AP2006/10/06Labeling Revision
020895021AP2005/07/08Labeling Revision
020895020AP2006/06/26Labeling Revision
020895018AP2002/09/19Efficacy Supplement with Clinical Data to Support
020895016AP2001/08/24Manufacturing Change or Addition
020895015AP2002/09/19Labeling Revision
020895014AP2001/08/24Manufacturing Change or Addition
020895012AP2002/01/02Labeling Revision
020895011AP2002/09/19Labeling Revision
020895010AP2000/03/16Manufacturing Change or Addition
020895009AP2000/01/20Control Supplement
020895008AP1999/11/16Control Supplement
020895007AP2002/02/14Manufacturing Change or Addition
020895006AP1999/06/18Labeling Revision
020895005AP2000/01/21Labeling Revision
020895004AP1998/12/22Labeling Revision
020895003AP1998/11/24Labeling Revision
020895002AP1998/08/13Labeling Revision
020895001AP1998/05/04Manufacturing Change or Addition
020895000AP1998/03/27Approval